DuPont Q3 sales beat estimates, lifts 2026 profit outlook

By Reuters News


Overview

  • US specialty materials maker's Q3 sales rose 4%, beating analyst expectations

  • Adjusted EPS for Q3 rose 62% yr/yr, beating analyst expectations

  • Company completed $250 mln accelerated share buyback, plans $250 mln more in Q4


Outlook

  • DuPont raises full-year 2026 adjusted EPS guidance to $7.47-$7.52 from prior outlook

  • Company expects full-year 2026 operating EBITDA of about $1.785 bln

  • DuPont forecasts Q4 2026 adjusted EPS of $1.90-$1.95 and net sales of about $1.825 bln


Result Drivers

  • ORGANIC SALES GROWTH - Co said mid-single-digit organic growth in Healthcare & Water Technologies and Diversified Industrials drove higher sales

  • SEGMENT EARNINGS - Co attributed adjusted EPS growth to higher segment earnings and lower net interest expense, tax rate, and share count

  • PRODUCTIVITY - Co said operating EBITDA and margin increased on organic growth and productivity


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$1.87 bln

$1.84 bln (12 Analysts)

Q3 Adjusted EPS

Beat

$2.09

$1.87 (17 Analysts)

Q3 Operating EBITDA

Beat

$469 mln

$449.40 mln (13 Analysts)

Q3 Operating EBITDA margin

25.10%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for DuPont de Nemours, Inc. is $160.00, about 13.2% above its November 2 closing price of $141.30

  • The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 18 three months ago


Reuters Recommended Reads

  • Nov 2 - Huntsman Q3 revenue beats estimates on higher sales volumes

  • Nov 2 - Chemours Q3 adjusted profit misses estimates despite titanium pricing gains

  • Nov 3 - Evonik Q3 core profit misses estimates, sees earnings at upper end of guidance


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.